Los Angeles, January 7, 2020 -QY Research recently published a research report, “Global (United States, European Union and China) Anti-inflammatory Therapeutics Market Research Report 2019-2025”. In 2018, the global anti-inflammatory therapeutics market size was US$92 bn and it is expected to reach US$139 bn by the end of 2025, rising at a CAGR of 6.11% during 2019-2025.
Get PDF sample copy of the report at: https://www.qyresearch.com/sample-form/form/1419830/global-united-states-european-union-and-china-anti-inflammatory-therapeutics-market
Autoimmune Diseases will Encourage Market to Gain Momentum
Increasing incidences of respiratory and inflammatory bowel diseases along with other conditions such as arthritis, multiple sclerosis, psoriasis, asthma, COPD are creating a global demand for anti-inflammatory therapeutics. These are increasingly used for patients with autoimmune disease to ease the pain due to inflammation. Anti-inflammatory therapeutics are also expected to be in demand due to growing investments in clinical trials and introduction of improved therapies.
The anti-inflammatory therapeutics are available in three types such as anti-inflammatory therapeutics, non-steroidal anti- inflammatory drugs, and corticosteroids. They can help in easing mild or acute chronic pain such as headaches, rheumatic arthritis, sprains, or even menstrual pain, providing faster relief to affected areas. Furthermore, they are able to lower prostaglandins levels and inflammation.
However, the side effects of these drugs such as dizziness, nausea, headaches, and diarrhea might hamper the growth of the market.
Nonsteroidal Anti-inflammatory Drug Segment to Grow Significantly
The nonsteroidal anti-inflammatory drug or NSAID segment will significantly grow in the forecast years as it takes lesser time to take effect with very few side effects than other drugs.
Asia Pacific to Become Fastest-growing Regional Market in Forecast Years
Over the years, rising awareness about health has contributed majorly to the growth of healthcare sector in Asia Pacific region. This is expected to help the market improve its status as the fastest-growing regional market. Countries like India and China house several leading pharmaceutical companies, which is expected propel the regional market.
Manufacturers to Focus in Developing New Therapeutic
AbbVie, leading global biopharmaceutical company recently announced its collaboration with Scripps Research, an international leader in non-profit biomedical research and drug discovery. Together, the companies are aiming to develop new therapeutic for a range of diseases. According to the terms of the agreement, Scripps will continue their pre-clinical R&D activities and even Phase 1 clinical trials in some cases. However, AbbVie will have an exclusive option to further develop and commercialize it.
The other major companies covered in the report includes TEVA, Johnson & Johnson, Sun Pharmaceutical Industries Ltd, Amgen Inc., GlaxoSmithKline, AstraZeneca PLC, Sanofi, Pfizer Inc., Novartis, Merck, Roche, and others.
QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert’s resources (included energy automotive chemical medical ICT consumer goods etc.
QY Research, INC.
17890 Castleton, Suite 218,
Los Angeles, CA – 91748
USA: +1 626 428 8800
China: +86 1082 945 717
Japan: +81 9038 009 273
India: +91 9766 478 224
Emails – firstname.lastname@example.org